Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07668687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

Study acronym: CEDAR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.
Trial Details
NCT Number NCT07668687
Lead Sponsor Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Conditions
(from sponsor)		 Dissection of Thoracic Aorta, Dissection of Thoracic Descending Aorta, Aneurysm of Aorta, Thoracic, Penetrating Aortic Ulcers (PAUs), Intramural Hematoma of the Thoracic Aorta, Ulcer-like Projection (ULP)
Related terms Aortic Aneurysm, Aortic Aneurysm, Thoracic, Aortic Intramural Hematoma, Dissection, Thoracic Aorta, Penetrating Atherosclerotic Ulcer
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov